Fig. 1From: Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudyKaplan–Meier curves illustrating time to all-cause mortality or all-cause hospitalization by quartile of metabolite factor 5 in diabetic participantsBack to article page